Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

EC Approves Additional Indication for Eisai's Anticancer Agent

May 10, 2016 2:00 pm | News | Comments

Halaven is a halichondrin class microtubule dynamics inhibitor with a distinct binding profile.

New Approach to Genetic Analysis Yields Markers to Complex Diseases

May 10, 2016 1:00 pm | by Anne Trafton, MIT News Office | News | Comments

Many diseases, such as cancer, diabetes, and schizophrenia, tend to be passed down through families.

TOPICS:

Takeda Receives Gates Foundation Grant for Polio Vaccine

May 10, 2016 10:30 am | by Ryan Bushey, Digital Editor | Articles | Comments

The Bill & Melinda Gates Foundation has awarded Takeda Pharmaceuticals a $38 million grant to support development of a low-cost polio vaccine.

TOPICS:
Advertisement

Allergan Plans to Buy Back $10B in Shares, Posts 1Q Profit

May 10, 2016 10:23 am | by The Associated Press | News | Comments

Allergan shares rose 2 percent in premarket trading.

TOPICS:

Better Way to Diagnose, Manage Neuroendocrine Tumors

May 10, 2016 8:56 am | by Society of Nuclear Medicine | News | Comments

These findings could have an impact on the future of nuclear medicine.

TOPICS:

Treating Hep C: Pay Now or Pay More Later

May 10, 2016 8:55 am | by University of Southern California | News | Comments

The economic studies were funded by the Illinois-based pharmaceutical company AbbVie.

TOPICS:

Valeant Pharma Promises to do Better with Deadlines

May 10, 2016 8:53 am | by The Associated Press | News | Comments

Shares of Valeant Pharmaceuticals are sharply higher after the embattled drug company promised to do better with financial filing deadlines.

TOPICS:

First U.S. Lab Network to Offer Epigenomics’ Epi proColon

May 10, 2016 8:53 am | News | Comments

Epigenomics AG, the German-American cancer molecular diagnostics company, announced that Laboratory Corporation of America Holdings (LabCorp) is the first laboratory network in the U.S. to offer Epi proColon, a blood-based test for colorectal cancer screening.

TOPICS:
Advertisement

Migraine Drugs Underused

May 10, 2016 8:40 am | by Thomas Jefferson University | News | Comments

Migraines are thought to cause pain because they cause a swelling of the blood vessels feeding the brain.

TOPICS:

Global Study Identifies Safer Acute Stroke Treatment

May 10, 2016 8:33 am | by University of Leicester | News | Comments

The safety of a controversial clot-busting drug has been investigated by researchers.

TOPICS:

Study Suggests New Treatment for Seizures

May 10, 2016 8:30 am | by eLife | News | Comments

Researchers have discovered a new factor in the escalation of seizures.

TOPICS:

Immunotherapy Drug Shows Long-Lasting Response in Advanced Melanoma

May 9, 2016 3:41 pm | by UCLA | News | Comments

Pembrolizumab produces positive responses that are long-lasting and with fewer side effects than traditional treatments in people with advanced melanoma.

TOPICS:

Gut-Brain Connection Moves into MS Territory

May 9, 2016 1:59 pm | by Harvard Gazette | News | Comments

Evidence suggests that bacteria living in the gut may remotely influence the activity of cells in the brain.

TOPICS:

RNAi-Based Therapeutics: A Novel Platform for Drug Development

May 9, 2016 10:18 am | by Geert Cauwenbergh, Dr. Med. Sc, President and CEO of RXi Pharmaceuticals Corporation | Articles | Comments

The discovery of a naturally occurring process known as RNAi (short for “RNA interference”) has enabled a new platform for drug development that can potentially serve as a basis for the creation of new types of therapeutics. 

TOPICS:

Providing Safe, Targeted Drug Delivery to Placenta During Pregnancy

May 9, 2016 9:44 am | by University of California - Santa Barbara | News | Comments

More than 10 percent of pregnant women develop serious complications during pregnancy. The underlying cause is often a poorly functioning placenta, the organ that nourishes and maintains the fetus.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading